Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Ltd has announced the issuance of new unquoted equity securities, including 550,000 convertible notes and 12,254,902 options expiring in September 2027 with an exercise price of $0.04284, as detailed in their latest Appendix 3G filing dated September 19, 2024. These securities are part of transactions previously disclosed and will not be quoted on the ASX.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
